Vascular Endothelial Growth Factor Levels in Patients Und... | NCT04261660

Studies
Vascular Endothelial Growth Factor Levels in Patients Undergoing Embryo Transfer

NCT04261660

Sponsor

Carmel Medical Center

Status

Unknown status

Last Update Posted

Feb 10, 2020Actual

Enrollment

90Estimated

Phase

Not provided

Conditions

Reproductive Techniques

Interventions

NO intervention

Countries

Not provided

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Feb 2020

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Not yet recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Mar 1, 2020Estimated

Primary Completion Date

Mar 1, 2021Estimated

Completion Date

Apr 1, 2021Estimated

First Submitted Date

Feb 6, 2020

First Submission Date that Met QC Criteria

Feb 7, 2020

First Posted Date

Feb 10, 2020Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Feb 7, 2020

Last Update Posted Date

Feb 10, 2020Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Yes

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

Assessing the relationship between the VEGF levels in blood and the IVF protocol

Detailed Description

The investigators are assessing the VEGF levels in the blood in IVF patients undergoing different protocols

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

Retention

Enrollment

90Estimated

Arms/Interventions Module

Arm Groups

Label	Description	Intervention Names
fresh	NO INTERVENTION	Other: NO intervention
Frozen embro transfer natural	NO INTERVENTION	Other: NO intervention
Frozen embro transfer hormonal	NO INTERVENTION	Other: NO intervention

Interventions

Name	Type	Description	Arm Group Labels	Other Names
NO intervention	Other	NO INTERVENTION	Frozen embro transfer hormonal Frozen embro transfer natural fresh

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
vascular endothelial growth factor LEVELS	levels of vascular endothelial growth factor in blood	5 days

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Patients undergoing IVF -

Exclusion Criteria:

Women with any malignancy
Patients request to be withdrawn

Accepts Healthy Volunteers

Not provided

Sex

Female

Sex/Gender Based

Yes

Sex/Gender Description

PATIENTS UNDERGOING IN VITRO FERTLIZATION

Minimum Age

18 Years

Maximum Age

40 Years

Standard Ages

Adult

Study Population

Female patients undergoing ovum pickup and embryo transfer as part of assited reproductive technologies

Sampling Method

Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
ido Fefekorn, MD	Contact	+972-54-3537401		idofe@clalit.org.il

Overall Officials

Name	Affiliation	Role
Ido Feferkorn, MD	Carmel Medical Center	Principal Investigator

Locations

Not provided

IPD Sharing Statement Module

Plan to Share IPD

Description

Not provided

Types

Not provided

Time Frame

Not provided

Access Criteria

Not provided

URL

Not provided